Table 1.
Baseline Characteristics of Patients with or Without H-Type Hypertension
| Baseline Characteristic | All | Non-H-type hypertension (n=43) | H-Type hypertension (n=172) | P value |
|---|---|---|---|---|
| Age, median (IQR), y | 69 (61–75) | 68 (64–76) | 69 (59–75) | 0.780 |
| Sex, No (%) | ||||
| Female | 87 (40.5) | 27 (62.8) | 60 (34.9) | 0.001 |
| Male | 128 (59.5) | 16 (37.2) | 112 (65.1) | |
| Medical history No. (%) | ||||
| Diabetes | 63 (29.3) | 11 (25.6) | 52 (30.2) | 0.55 |
| Cerebral infarction | 45 (20.9) | 12 (27.9) | 33 (19.2) | 0.21 |
| Atrial fibrillation | 61 (28.4) | 15 (34.9) | 46 (26.7) | 0.29 |
| Hyperlipidemia | 31 (14.4) | 6 (14.0) | 25 (14.5) | 0.92 |
| Smoking | 61 (28.4) | 8 (18.6) | 53 (30.8) | 0.11 |
| Prestroke antithrombotictreatment No. (%) | ||||
| Oral anticoagulant | 26 (12.1) | 5 (11.6) | 21 (32.2) | 0.92 |
| Mono-antiplatelet treatment | 12 (5.6) | 5 (11.6) | 7 (4.1) | 0.05 |
| Stroke etiology No. (%) | ||||
| LAA | 124 (57.7) | 21 (48.8) | 103 (59.9) | 0.40 |
| CE | 70 (32.6) | 17 (39.5) | 53 (30.8) | |
| Other | 21 (9.8) | 5 (11.6) | 16 (9.3) | |
| NIHSS score, median (IQR) | 16 (11–19) | 16 (12–20) | 15 (11–19) | 0.38 |
| Onset to puncture(minutes)(IQR) | 380 (232–614) | 283 (210–510) | 400 (246–682) | 0.03 |
| Imaging characteristics | ||||
| ASPECTS score, median (IQR) | 8 (7–9) | 8 (7–9) | 8 (6–9) | 0.78 |
| Occlusion site – No. (%) | ||||
| Intracranial internal carotid artery | 48 (22.3) | 6 (14) | 42 (24.4) | 0.18 |
| M1 middle cerebral artery segment | 139(64.7) | 33 (76.7) | 106 (61.6) | |
| M2 middle cerebral artery segment | 28 (13.0) | 4 (9.3) | 24 (14.0) | |
| Tirofiban (%) | 102 (47.4) | 17 (39.5) | 85 (49.4) | 0.25 |
Abbreviations: LAA, Large artery atherosclerosis; CE, Cardioembolism; NIHSS, National Institutes of Health Stroke Scale; ASPECTS, Alberta stroke program early CT score.